SCHEMBL26854525

SCHEMBL26854525

CC(C)OCc1cc(Cl)[nH]n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26854315 0.65 KDM4E (0.35) —
SCHEMBL26871831 0.64 POLB (0.30) —
SCHEMBL26856154 0.64 — —
SCHEMBL27151383 0.64 SIRT6 (0.33) —
SCHEMBL19267405 0.63 NTRK1 (0.34) —
SCHEMBL21737145 0.63 — —
SCHEMBL29197105 0.63 — —
SCHEMBL22282082 0.63 — —
SCHEMBL24622008 0.62 COMT (0.39) —
SCHEMBL17069262 0.61 IDO1 (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023230190-A1 PYRIMIDINE BASED MODULATORS AND USES THEREOF QUANTA THERAPEUTICS, INC. (US) 2023-11-30 — — WO disclosed
Send feedback